NY Federal Court Won't Rethink Cymbalta Labeling Suit

Law360, New York (February 26, 2015, 4:18 PM EST) -- A New York federal judge on Thursday declined to review a suit against Eli Lilly & Co. over the labeling of its antidepressant Cymbalta that allegedly downplays its withdrawal symptoms, finding that the plaintiff had not introduced any new evidence that warranted a new look at the case.

U.S. District Judge Robert Sweet denied a motion by plaintiff Jesse McDowell to reconsider his summary judgment ruling for Eli Lilly, saying expert reports he had submitted since the ruling did not contain any new information that was...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

McDowell v. Eli Lilly and Company


Case Number

1:13-cv-03786

Court

New York Southern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Robert W. Sweet

Date Filed

June 4, 2013

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.